Dallas, TX (PRWEB) October 23, 2009
In October of 2008, a warning letter was sent by the Food and Drug Administration to Bayer HealthCare Pharmaceuticals, Inc., in response to claims the company had made for Yaz, its popular and heavily promoted birth control pill.
The warning letter stated that Yaz has additional reported risks not present in other birth control pills because it contains drospirenone, a progestin hormone that can increase potassium levels. Each tablet of Yaz contains 3 mg drospirenone; each tablet of Yasmine contains 3 mg drospirenone.
According to the FDA, drospirenone can lead to hyperkalemia, a condition caused by excessive amounts of potassium in the blood of high risk patients, resulting in potentially serious heart and health problems. Among the serious and debilitating injuries reported from drospirenone in birth control are heart attacks, blood clots, strokes, pulmonary embolisms, deep vein thrombosis, liver or kidney failure, pancreatitis, gall bladder disease, and other serious injuries. Some patients have even died.
Yaz was approved for use in the US market in 2006, and Yasmin was approved in 2001. The FDA is reported to have received more data about the serious side effects of Yaz and Yasmin than other birth control pills on the market much longer.
Yaz and Yasmin (drospirenone/ethinyl estradiol) are oral contraceptive combination drugs, combining the hormones estrogen (ethinyl estradiol) and progestin (drospirenone).
The difference between these two drugs is the amount of estrogen that they contain: Yasmin has 30 mcg estrogen, while Yaz has slightly less, 20 mcg estrogen. The drugs work by preventing ovulation and also cause changes in the lining of the uterus; it is more difficult for a sperm to reach the uterus and for an egg that is fertilized to attach to the uterus.
Yaz and Yasmin have three FDA-approved uses: Pregnancy prevention, alleviation of premenstrual dysphoric disorder (PMDD), and treatment of moderate acne in women who would want to use an oral contraceptive for birth control. Yasmin and Yaz dominate the contraceptive market in the US, with an estimated 25% market share. Yaz alone is the top-selling birth control pill in the United States (2008 figures).
The most commonly reported side-effects to Yaz and Yasmin are relatively mild, such as decrease in sex drive, weight gain, nausea and vomiting, headaches, susceptibility to yeast infections, vaginal discharge, and breakthrough bleeding or spotting.
However, very severe responses to the drug, even death, have been reported, including:
- Heart attack
- Pulmonary embolism
- Blood Clots
- Cardiac arrhythmia
- Deep vein thrombosis
- Gall bladder disease or gallstones
- Liver, kidney, or other organ failure
- Dehydration or elevated potassium levels (hyperkalemia)
Never stop taking any prescription medication without first speaking with your physician.
About The Mulligan Law Firm
The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.
The Mulligan Law Firm is currently investigating injury claims involving the possible role of Yaz and Yasmin in the development of hyperkalemia and heart, circulatory and organ problems. If you or someone you know has experienced these problems after taking Yaz or Yasmin, consult with a legal professional immediately - contact Eric Gruenwald, Lawyer / Attorney, at (866) 529-0001, Ext. 245. The Mulligan Law Firm has experienced lawyers ready to help.
All cases are taken on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.
For more information on The Mulligan Law Firm, see http://www.mulliganlaw.com/
For more information on the side-effects of Yaz and Yasmin, see http://www.mulliganlaw.com/yazyasmin.html
Yaz and Yasmin informational blog entries: http://www.mulliganlaw.com/blog/
# # #